PKMYT1, a potential ‘Achilles heel’ of treatment resistant ER+ breast cancers with the poorest prognosis
The challenge was to identify the kinase among hundreds of kinases in these treatment-resistant tumors that would help turn the tide in the fight against this cancer.
Read More